Cryoglobulinemia-related vasculitis during effective anti-HCV treatment with PEG-interferon alfa-2b

Infection

Volumn 36, Issue 3, 2008, Pages 285-287

  De Blasi, T ^a   Aguilar Marucco, D ^a   Cariti, G ^a   Maiello, A ^a   De Rosa, F G ^a   Di Perri, G ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; AMANTADINE; ANTIHYPERTENSIVE AGENT; DIURETIC AGENT; HEPATITIS B CORE ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; METHYLPREDNISOLONE; PEGINTERFERON ALPHA2B; RHEUMATOID FACTOR; VIRUS RNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANAMNESIS; ARTHRALGIA; ARTICLE; CASE REPORT; CRYOGLOBULINEMIA; DRUG EFFICACY; DRUG WITHDRAWAL; EMERGENCY WARD; HEPATITIS C; HEPATITIS C VIRUS; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; HYPERTENSION; KIDNEY BIOPSY; KIDNEY FUNCTION; LABORATORY TEST; MALE; PERIPHERAL NEUROPATHY; PURPURA; REMISSION; VASCULITIS;

ADULT; AMANTADINE; ANTIVIRAL AGENTS; CRYOGLOBULINEMIA; DRUG THERAPY, COMBINATION; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2B; MALE; TREATMENT OUTCOME; VASCULITIS;

EID: 45749142121     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/s15010-007-6299-1     Document Type: Article

References (16)

1. Johnson RJ, Gretch DR, Hideaki Y, Hart J, Bacchi C, et al. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med 1993; 328: 465-470.
2. Cacoub P, Renou C, Rosenthal E, Cohen P, Loury I, et al. Extrahepatic manifestations associated with hepatitis C virus infection: a prospective multicenter study. Medicine 2000; 79: 47-56.
3. Lunel F, Musset L, Cacoub P, et al. Cryoglobulinemia in chronic liver diseases: role of hepatitis C virus and liver damage. Gastroenterology 1994; 106: 1291-1300.
4. Cacoub P, Poynard T, Ghilliani P, Palla P, Moretti A, et al. Extra hepatic manifestations of chronic hepatitis C. Arthritis Rheum 1999; 42: 2204-2212.
5. Naarendorp M, Kallemuchikkal U, Nuovo G, Gorevic P: Longterm efficacy of interferon alpha for extra hepatic disease associated with hepatitis C virus infection. J Rheumatol 2001; 28: 2466-2473.
6. Cresta P, Musset L, Cacoub P, Franguel L, Vitour D, et al. Response to interferon a treatment and disappearance of cryogloblinaemia in patients infected by hepatitis C virus. Gut 1999; 45: 122-128.
7. Akbar AN, Lord JM, Salmon M: INF-alpha and INF-beta: a link between immune memory and chronic inflammation. Immunol Today 2000; 21: 337-342.
8. Misiani R, Bellavita P, Fenili DF, Vicari A, Marchesi D, Sironi PL, et al. Interferon alfa-2a therapy in cryogloblinaemia associated with hepatitis C virus. N Engl J Med 1994; 330: 751-756.
9. Alric L, Plaisier E, Thebault S, Peron JM, Rostaing L, et al. Influence of antiviral therapy in hepatitis C virus-associated cryoglobulinemic MPGN. AJKD 2004; 33: 4.
10. Cacoub P, Lidove O, Maisonobe T, Duhaut P, Thilbaut V, et al. Interferon-a and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis. Arthritis Rheum 2002; 12: 3317-3326.
11. Rossi P, Bertani T, Baio P, Caldara R, Luliri P, et al. Hepatitis C virus-related cryoglobulinemic glomerulonephritis: long-term remission after antiviral therapy. Kidney Int 2003; 63: 2236-2241.
12. Bojic I, Lilic D, Radojcic C, Mijuskovic P: Deterioration of mixed cryoglobulinemia during treatment with interferon alpha-2a. J Gastroenterol 1994; 29: 369-371.
13. Gordon ACH, Edgar JMD, Finch RG: Acute exacerbation of vasculitis during interferon-alpha therapy for hepatitis C associated cryoglobuliaemia. J Infect 1998; 36: 229-230.
14. Friedman G, Metha S, Sherker AH: Fatal exacerbation of hepatitis C-related cryioglobulinemia with interferon-alpha. Dig Dis Sci 1999; 44: 1364-1365.
15. Misiani R, Bellavita P, Baio P, Caldara R, Ferruzzi S, et al. Successful treatment of HCV-associated cryoglobulinaemic glomerulonephritis with a combination of interferon-a and ribavirin. Nephrol Dial Transplant 1999; 14: 1558-1560.
16. Batisse D, Karmochkine M, Jacquot C, Kazatchkine MD, Weiss L: Sustained exacerbation of cryoglobulinaemia-related vasculitis following treatment of hepatitis C with peginterferon alfa. Eur J Gastroenterol Hepatol 2004; 16: 701-703.